1,378
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Patient-reported outcome measures in severe asthma: an expert consensus

, MD, PhD, , MD, PhD, , PharmD PhDORCID Icon, , , MD PhD, , PharmD PhD, , MD PhD, , PharmD PhD, , NursingD, , MD PhD, , PharmD, , MD PhD, , MD PhD, , MD, , PharmD, , NursingD, , PharmD PhD, , PharmD, , MD, , PharmD, , PharmD PhD, , PharmD & , MD PhD show all
Pages 619-631 | Received 16 Oct 2023, Accepted 16 Dec 2023, Published online: 26 Dec 2023

References

  • The global asthma report 2018. Global asthma network; 2018. Available from: http://globalasthmareport.org.
  • Hekking PW, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896–902. doi:10.1016/j.jaci.2014.08.042.
  • GEMA 5.1. Guía Española para el Manejo del Asma: Sociedad Española de Neumología y Cirugía Torácica. 2021.
  • Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, et al. Global Initiative for Asthma Strategy 2021: Executive summary and rationale for key changes. Eur Respir J. 2022;59(1):2102730. doi:10.1183/13993003.02730-2021.
  • Global Initiative for Asthma (GINA) 2021. Available from: https://www.ginasthma.com/.
  • Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:10.1183/09031936.00202013.
  • Upham JW, Le Lievre C, Jackson DJ, Masoli M, Wechsler ME, Price DB, Delphi panel defining a severe asthma super-responder: findings from a Delphi process. J Allergy Clin Immunol Pract. 2021;9(11):3997–4004. doi:10.1016/j.jaip.2021.06.041.
  • McDonald VM, Hiles SA, Jones KA, Clark VL, Yorke J. Health-related quality of life burden in severe asthma. Med J Aust. 2018;209(S2):S28–S33. doi:10.5694/mja18.00207.
  • Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald JM, Gibson P, Ohta K, O’Byrne P, Pedersen SE, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31(1):143–178. doi:10.1183/09031936.00138707.
  • Santino TA, Monteiro KS, de Paiva Azevedo M, Patino CM, Ahmed S, de Mendonça K. Patient- and proxy-reported outcome measures instruments for the assessment of asthma control among adult and pediatric population: A protocol for systematic review. Medicine (Baltimore). 2020;99(19):e20078. doi:10.1097/MD.0000000000020078.
  • Song HJ, Blake KV, Wilson DL, Winterstein AG, Park H. Medical costs and productivity loss due to mild, moderate, and severe asthma in the United States. J Asthma Allergy. 2020;13:545–555. doi:10.2147/JAA.S272681.
  • Martínez-Moragón E, Serra-Batllés J, De Diego A, Palop M, Casan P, Rubio-Terrés C, Pellicer C; por el Grupo de Investigadores del estudio AsmaCost [Economic cost of treating the patient with asthma in Spain: The AsmaCost study]. Arch Bronconeumol. 2009;45(10):481–486. doi:10.1016/j.arbres.2009.04.006.
  • Kroes JA, Zielhuis SW, van der Meer AN, de Jong K, Ten Brinke A, van Roon EN. Patient-reported outcome measures after 8 weeks of mepolizumab treatment and long-term outcomes in patients with severe asthma: An observational study. Int J Clin Pharm. 2021;44(2):570–574. doi:10.1007/s11096-021-01362-8.
  • Corren J, Garcia Gil E, Griffiths JM, Parnes JR, van der Merwe R, Sałapa K, O’Quinn S. Tezepelumab improves patient-reported outcomes in patients with severe, uncontrolled asthma in PATHWAY. Ann Allergy Asthma Immunol. 2021;126(2):187–193. doi:10.1016/j.anai.2020.10.008.
  • Chen J, Ou L, Hollis SJ. A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res. 2013;13(1):211. doi:10.1186/1472-6963-13-211.
  • Basch E, Barbera L, Kerrigan CL, Velikova G. Implementation of patient-reported outcomes in routine medical care. Am Soc Clin Oncol Educ Book. 2018;38:122–134. doi:10.1200/EDBK_200383.
  • Braido F, Baiardini I, Canonica GW. Patient-reported outcomes in asthma clinical trials. Curr Opin Pulm Med. 2018;24(1):70–77. doi:10.1097/MCP.0000000000000440.
  • Worth A, Hammersley V, Knibb R, Flokstra-de-Blok B, DunnGalvin A, Walker S, et al. Patient-reported outcome measures for asthma: A systematic review. NPJ Prim Care Respir Med. 2014;24:14020.
  • Hyland ME, Lanario JW, Menzies-Gow A, Mansur AH, Dodd JW, Fowler SJ, Hayes G, Jones RC, Masoli M. Comparison of the sensitivity of patient-reported outcomes for detecting the benefit of biologics in severe asthma. Chron Respir Dis. 2021;18:14799731211043530. doi:10.1177/14799731211043530.
  • Kocks JWH, Seys SF, van Duin TS, Diamant Z, Tsiligianni IG. Assessing patient-reported outcomes in asthma and COPD patients: Which can be recommended in clinical practice? Curr Opin Pulm Med. 2018;24(1):18–23. doi:10.1097/MCP.0000000000000447.
  • Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097.
  • Glaser BG, Strauss AL. The discovery of grounded theory: Strategies for qualitative research. New York: Aldine Publishing Company; 1967.
  • Gallagher M, Hares T, Spencer J, Bradshaw C, Webb I. The nominal group technique: A research tool for general practice? Fam Pract. 1993;10(1):76–81. doi:10.1093/fampra/10.1.76.
  • McMillan SS, King M, Tully MP. How to use the nominal group and Delphi techniques. Int J Clin Pharm. 2016;38(3):655–662. doi:10.1007/s11096-016-0257-x.
  • Sinha IP, Smyth RL, Williamson PR. Using the Delphi technique to determine which outcomes to measure in clinical trials: Recommendations for the future based on a systematic review of existing studies. PLoS Med. 2011;8(1):e1000393. doi:10.1371/journal.pmed.1000393.
  • Birko S, Dove ES, Özdemir V. Evaluation of nine consensus indices in delphi foresight research and their dependency on Delphi survey characteristics: A simulation study and debate on Delphi design and interpretation. PLoS One. 2015;10(8):e0135162. doi:10.1371/journal.pone.0135162.
  • Diamond IR, Grant RC, Feldman BM, Pencharz PB, Ling SC, Moore AM, Wales PW. Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014;67(4):401–409. doi:10.1016/j.jclinepi.2013.12.002.
  • Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J. 1999;14(1):32–38. doi:10.1034/j.1399-3003.1999.14a08.x.
  • Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: A survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59–65. doi:10.1016/j.jaci.2003.09.008.
  • Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003;58(4):339–343. doi:10.1136/thorax.58.4.339.
  • de los Santos G, Reyes P, del Castillo R, Fragola C, Royuela A. Cross-cultural adaptation and validation of the sino-nasal outcome test (SNOT-22) for Spanish-speaking patients. Eur Arch Otorhinolaryngol. 2015;272(11):3335–3340. doi:10.1007/s00405-014-3437-0.
  • Morin CM, Belleville G, Bélanger L, Ivers H. The Insomnia Severity Index: Psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601–608. doi:10.1093/sleep/34.5.601.
  • EuroQol: EQ-5D instruments. Available from: https://euroqol.org/eq-5d-instruments/.
  • Bharmal M, Payne K, Atkinson MJ, Desrosiers MP, Morisky DE, Gemmen E. Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications. Health Qual Life Outcomes. 2009;7(1):36. doi:10.1186/1477-7525-7-36.
  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x.
  • mMRC (Modified Medical Research Council). Dyspnea scale. Available from: https://www.mdcalc.com/mmrc-modified-medical-research-council-dyspnea-scale#:∼:text=The%20mMRC%20Dyspnea%20Scale%20quantifies,obstructive%20pulmonary%20disease%20(COPD).
  • Grammatopoulou EP, Skordilis EK, Georgoudis G, Haniotou A, Evangelodimou A, Fildissis G, Katsoulas T, Kalagiakos P. Hyperventilation in asthma: A validation study of the Nijmegen Questionnaire–NQ. J Asthma. 2014;51(8):839–846. doi:10.3109/02770903.2014.922190.
  • Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. doi:10.1016/0165-1781(89)90047-4.
  • Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi:10.1097/00005650-198601000-00007.
  • Plaza V, López-Viña A, Cosio BG; en representación del Comité Científico del Proyecto TAI. Test of adherence to inhalers. Arch Bronconeumol. 2017;53(7):360–361. doi:10.1016/j.arbres.2016.08.006.
  • Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–365. doi:10.2165/00019053-199304050-00006.
  • Tejwani V, Chang H-Y, Tran AP, Naber JA, Gutzwiller FS, Winders TA, Khurana S, Sumino K, Mosnaim G, Moloney RM, et al. A multistakeholder Delphi consensus core outcome set for clinical trials in moderate-to-severe asthma (coreASTHMA). Ann Allergy Asthma Immunol. 2021;127(1):116–122.e7. doi:10.1016/j.anai.2021.03.022.
  • Osman LM, McKenzie L, Cairns J, Friend JA, Godden DJ, Legge JS, Douglas JG. Patient weighting of importance of asthma symptoms. Thorax. 2001;56(2):138–142. doi:10.1136/thorax.56.2.138.
  • Porsbjerg C, Menzies-Gow A. Co-morbidities in severe asthma: Clinical impact and management. Respirology. 2017;22(4):651–661. doi:10.1111/resp.13026.
  • Global Initiative for Asthma (GINA) 2023. Available from: https://ginasthma.org/severeasthma/.
  • Di Bona D, Minenna E, Albanesi M, Nettis E, Caiaffa MF, Macchia L. Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: data from a real-life cohort. Pulm Pharmacol Ther. 2020;64:101974. doi:10.1016/j.pupt.2020.101974.
  • Worth A, Hammersley VS, Nurmatov U, Sheikh A. Systematic literature review and evaluation of patient reported outcome measures (PROMs) for asthma and related allergic diseases. Prim Care Respir J. 2012;21(4):455–458. doi:10.4104/pcrj.2012.00084.
  • Sunjaya A, Poulos L, Reddel H, Jenkins C. Qualitative validation of the modified Medical Research Council (mMRC) dyspnoea scale as a patient-reported measure of breathlessness severity. Respir Med. 2022;203:106984. doi:10.1016/j.rmed.2022.106984.
  • Alvarez-Gutiérrez FJ, Blanco-Aparicio M, Casas-Maldonado F, Plaza V, González-Barcala FJ, Carretero-Gracia JÁ, Castilla-Martínez M, Cisneros C, Diaz-Pérez D, Domingo-Ribas C, et al. Consensus document for severe asthma in adults. 2022 update. Open Respir Arch. 2022;4(3):100192. doi:10.1016/j.opresp.2022.100192.
  • Foster A, Croot L, Brazier J, Harris J, O’Cathain A. The facilitators and barriers to implementing patient reported outcome measures in organisations delivering health related services: A systematic review of reviews. J Patient Rep Outcomes. 2018;2(1):46. doi:10.1186/s41687-018-0072-3.
  • Philpot LM, Barnes SA, Brown RM, Austin JA, James CS, Stanford RH, Ebbert JO. Barriers and benefits to the use of patient-reported outcome measures in routine clinical care: A qualitative study. Am J Med Qual. 2018;33(4):359–364. doi:10.1177/1062860617745986.
  • Field J, Holmes MM, Newell D. PROMs data: Can it be used to make decisions for individual patients? A narrative review. Patient Relat Outcome Meas. 2019;10:233–241. doi:10.2147/PROM.S156291.
  • Qamar N, Pappalardo AA, Arora VM, Press VG. Patient-centered care and its effect on outcomes in the treatment of asthma. Patient Relat Outcome Meas. 2011;2:81–109. doi:10.2147/PROM.S12634.
  • Clark VL, Gibson PG, McDonald VM. What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance. ERJ Open Res. 2021;7(1):00497–2020. doi:10.1183/23120541.00497-2020.